A new method to measure how well patients take their cancer medications

A novel algorithm to compute adherence from electronic adherence monitoring devices

NIH-funded research Cincinnati Childrens Hosp Med Ctr · NIH-10698066

This study is all about finding better ways to help cancer patients stick to their medication schedules by using special devices that track when they open their medicine containers, so we can create a smart tool that makes it easier for doctors to see how well patients are following their treatment plans.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionCincinnati Childrens Hosp Med Ctr NIH-funded
Lab location1 site (Cincinnati, United States)
Project IDNIH-10698066 on NIH RePORTER

What this research studies

This research focuses on improving the way we track medication adherence for cancer patients using electronic adherence monitoring devices (EAMDs). These devices record when patients open their medication containers, providing precise data on their medication-taking habits. The study aims to develop a new algorithm that accurately converts this raw data into useful adherence information, making it easier for healthcare providers to understand and support patients' medication routines. A multidisciplinary team will be involved in designing the algorithm and its user interface, ensuring it meets the needs of both patients and clinicians.

Who could benefit from this research

Good fit: Ideal candidates for this research are cancer patients who are prescribed medication and use electronic adherence monitoring devices.

Not a fit: Patients who do not use electronic adherence monitoring devices or are not undergoing treatment for cancer may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to better tracking of medication adherence, ultimately improving treatment outcomes for cancer patients.

How similar studies have performed: Previous research has shown promise in using electronic monitoring for medication adherence, indicating that this approach could be effective.

Where this research is happening

Cincinnati, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Anti-Cancer AgentsCancer DrugNeoplastic Disease Chemotherapeutic Agentsanti-cancer druganticancer agent
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.